
Upcoming first-line chemotherapy for HER2-negative gastric cancer in Japan: which patients benefit from immunotherapy?
Author(s) -
Daisuke Takahari,
Keisho Chìn,
Kensei Yamaguchi
Publication year - 2020
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2020-0421
Subject(s) - medicine , cancer , immunotherapy , chemotherapy , oncology